Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bellatrix Pharmaceuticals was a specialty pharmaceutical company based in Princeton, New Jersey, that focused on the development and commercialization of branded prescription products for the dermatology and podiatry markets. The company's portfolio featured several topical treatments, including Venelex for wound care, Bionect for skin irritation, and MimyX for atopic dermatitis. Bellatrix operated as a subsidiary of Pinnacle Biologics and was eventually absorbed into the broader portfolio of Concordia Healthcare (now Advanz Pharma) following its acquisition of Pinnacle. The company primarily targeted healthcare professionals in the wound care and skin health sectors with specialized therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bellatrix Pharmaceuticals.